Literature DB >> 25047708

Evolutionary constraints or opportunities?

Alexei A Sharov1.   

Abstract

Natural selection is traditionally viewed as a leading factor of evolution, whereas variation is assumed to be random and non-directional. Any order in variation is attributed to epigenetic or developmental constraints that can hinder the action of natural selection. In contrast I consider the positive role of epigenetic mechanisms in evolution because they provide organisms with opportunities for rapid adaptive change. Because the term "constraint" has negative connotations, I use the term "regulated variation" to emphasize the adaptive nature of phenotypic variation, which helps populations and species to survive and evolve in changing environments. The capacity to produce regulated variation is a phenotypic property, which is not described in the genome. Instead, the genome acts as a switchboard, where mostly random mutations switch "on" or "off" preexisting functional capacities of organism components. Thus, there are two channels of heredity: informational (genomic) and structure-functional (phenotypic). Functional capacities of organisms most likely emerged in a chain of modifications and combinations of more simple ancestral functions. The role of DNA has been to keep records of these changes (without describing the result) so that they can be reproduced in the following generations. Evolutionary opportunities include adjustments of individual functions, multitasking, connection between various components of an organism, and interaction between organisms. The adaptive nature of regulated variation can be explained by the differential success of lineages in macro-evolution. Lineages with more advantageous patterns of regulated variation are likely to produce more species and secure more resources (i.e., long-term lineage selection). Published by Elsevier Ireland Ltd.

Keywords:  Developmental correlation; Multitasking; Phenotypic plasticity; Regulated variation; Units of selection, macro-evolution

Mesh:

Year:  2014        PMID: 25047708     DOI: 10.1016/j.biosystems.2014.06.004

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  10 in total

Review 1.  Coenzyme world model of the origin of life.

Authors:  Alexei A Sharov
Journal:  Biosystems       Date:  2016-03-09       Impact factor: 1.973

2.  Evolutionary biosemiotics and multilevel construction networks.

Authors:  Alexei A Sharov
Journal:  Biosemiotics       Date:  2016-08-16       Impact factor: 0.711

3.  Composite Agency: Semiotics of Modularity and Guiding Interactions.

Authors:  Alexei A Sharov
Journal:  Biosemiotics       Date:  2017-07-27       Impact factor: 0.711

4.  Evolution of natural agents: preservation, advance, and emergence of functional information.

Authors:  Alexei A Sharov
Journal:  Biosemiotics       Date:  2016-04       Impact factor: 0.711

5.  Comprehending the Semiosis of Evolution.

Authors:  Alexei Sharov; Timo Maran; Morten Tønnessen
Journal:  Biosemiotics       Date:  2016-04       Impact factor: 0.711

6.  The Semiosis of "Side Effects" in Genetic Interventions.

Authors:  Ramsey Affifi
Journal:  Biosemiotics       Date:  2016-10-15       Impact factor: 0.711

Review 7.  The Human-Nature Relationship and Its Impact on Health: A Critical Review.

Authors:  Valentine Seymour
Journal:  Front Public Health       Date:  2016-11-18

8.  Introns provide a platform for intergenic regulatory feedback of RPL22 paralogs in yeast.

Authors:  Kateřina Abrhámová; Filip Nemčko; Jiří Libus; Martin Převorovský; Martina Hálová; František Půta; Petr Folk
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

9.  Phenotypes to remember: Evolutionary developmental memory capacity and robustness.

Authors:  András Szilágyi; Péter Szabó; Mauro Santos; Eörs Szathmáry
Journal:  PLoS Comput Biol       Date:  2020-11-30       Impact factor: 4.475

10.  The Natural Emergence of (Bio)Semiosic Phenomena.

Authors:  J H van Hateren
Journal:  Biosemiotics       Date:  2015-05-27       Impact factor: 0.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.